![Matthew Gantz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Gantz
Chief Executive Officer at
Castle Creek Biosciences, Inc.
Profile
Mr. Matthew Gantz is a Chairman, President & Chief Executive Officer at Castle Creek Biosciences, Inc. He is on the Board of Directors at Marine Corps Scholarship Foundation.
Mr. Gantz was previously employed as a Chief Executive Officer by OxThera AB, an Independent Director by Swedish Orphan Biovitrum AB, an Executive Vice President by BTG International, Inc., an Executive Vice President by BTG Plc, a Chief Executive Officer by Acureon Pharmaceuticals, Inc., a Vice President-Europe, Biopharmaceutical Division by Chiron Corp., a General Manager-Europe by PathoGenesis Corp, a Principal by Abbott Laboratories Ltd., a President & Chief Executive Officer by Hydra Biosciences, Inc., a President by PneumRx LLC, and a Principal by United States Marine Corps.
He also served on the board at Life Sciences Pennsylvania.
He received his undergraduate degree from Princeton University and an MBA from Harvard Business School.
Matthew Gantz active positions
| Companies | Position | Start |
|---|---|---|
Marine Corps Scholarship Foundation
 Marine Corps Scholarship Foundation Investment Trusts/Mutual FundsMiscellaneous Provides scholarships services to military children | Director/Board Member | - |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Chief Executive Officer | 01/03/2021 |
Former positions of Matthew Gantz
| Companies | Position | End |
|---|---|---|
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Chief Executive Officer | 01/03/2021 |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Chief Investment Officer | 01/06/2016 |
| BTG | Corporate Officer/Principal | 01/06/2016 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01/01/2003 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Corporate Officer/Principal | 01/01/2000 |
Training of Matthew Gantz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
PneumRx LLC
 PneumRx LLC Medical SpecialtiesHealth Technology Operates as a medical device company which focuses on developing minimally-invasive solutions for unmet medical needs in pulmonary medicine | Health Technology |
Acureon Pharmaceuticals, Inc.
 Acureon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops & markets therapeutics for infectious diseases | Retail Trade |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
United States Marine Corps
 United States Marine Corps SovereignGovernment Provides marine armed force services | Government |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Abbott Laboratories Ltd.
 Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, develops and sells pharmaceutical and nutritional products | Health Technology |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Marine Corps Scholarship Foundation
Marine Corps Scholarship Foundation Investment Trusts/Mutual FundsMiscellaneous Provides scholarships services to military children | Miscellaneous |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
- Stock Market
- Insiders
- Matthew Gantz
